[go: up one dir, main page]

MX2017002972A - Pirrolopirimidinas para usarse en la infeccion por el virus de la gripe. - Google Patents

Pirrolopirimidinas para usarse en la infeccion por el virus de la gripe.

Info

Publication number
MX2017002972A
MX2017002972A MX2017002972A MX2017002972A MX2017002972A MX 2017002972 A MX2017002972 A MX 2017002972A MX 2017002972 A MX2017002972 A MX 2017002972A MX 2017002972 A MX2017002972 A MX 2017002972A MX 2017002972 A MX2017002972 A MX 2017002972A
Authority
MX
Mexico
Prior art keywords
pyrrolopyrimidines
influenza virus
virus infection
compounds
formula
Prior art date
Application number
MX2017002972A
Other languages
English (en)
Inventor
Werner Constant Johan Embrechts
Pierre Jean-Marie Bernard Raboisson
Gowan David Craig Mc
Tim Hugo Maria Jonckers
Jérôme Émile Georges Guillemont
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of MX2017002972A publication Critical patent/MX2017002972A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invención se refiere a compuestos que tienen la estructura de fórmula (I) que se pueden utilizar para el tratamiento de infecciones de la gripe o contra estas. (ver Fórmula).
MX2017002972A 2014-09-08 2015-09-07 Pirrolopirimidinas para usarse en la infeccion por el virus de la gripe. MX2017002972A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14183984 2014-09-08
PCT/EP2015/070316 WO2016037953A1 (en) 2014-09-08 2015-09-07 Pyrrolopyrimidines for use in influenza virus infection

Publications (1)

Publication Number Publication Date
MX2017002972A true MX2017002972A (es) 2017-05-30

Family

ID=51535336

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017002972A MX2017002972A (es) 2014-09-08 2015-09-07 Pirrolopirimidinas para usarse en la infeccion por el virus de la gripe.

Country Status (22)

Country Link
US (1) US9932346B2 (es)
EP (1) EP3191489B1 (es)
JP (1) JP6718451B2 (es)
KR (1) KR102531340B1 (es)
CN (1) CN106661036B (es)
AU (1) AU2015314394A1 (es)
BR (1) BR112017004524A2 (es)
CA (1) CA2957475A1 (es)
CL (1) CL2017000533A1 (es)
DK (1) DK3191489T3 (es)
EA (1) EA201790571A1 (es)
ES (1) ES2860688T3 (es)
HR (1) HRP20210038T1 (es)
HU (1) HUE053595T2 (es)
IL (1) IL250955A0 (es)
LT (1) LT3191489T (es)
MX (1) MX2017002972A (es)
PH (1) PH12017500393A1 (es)
SG (1) SG11201701621YA (es)
SI (1) SI3191489T1 (es)
WO (1) WO2016037953A1 (es)
ZA (1) ZA201701643B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201405826RA (en) 2009-06-17 2014-12-30 Vertex Pharma Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP3294735B8 (en) 2015-05-13 2022-01-05 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルスの複製の阻害剤を調製する方法
AU2016368317B2 (en) 2015-12-09 2019-05-23 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
KR20180099839A (ko) * 2016-01-07 2018-09-05 얀센 사이언시즈 아일랜드 유씨 인플루엔자 바이러스 감염에서 사용하기 위한 작용화된 펜탄산
WO2017133669A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh 5, 7-diazaindole and 5, 7-diazaindazole derivatives and their use in the treatment, amelioration or prevention of influenza
WO2017133665A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh 6,7-diazaindazole and 6,7-diazaindole derivatives and use in treatment, amelioration or prevention of influenza thereof
CN107759571B (zh) 2016-08-16 2021-03-02 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
CN106316886A (zh) * 2016-08-24 2017-01-11 泰州精英化成医药科技有限公司 顺式‑3‑（叔丁氧羰基氨基）环己烷甲酸的制备方法
CN109641868B (zh) * 2016-08-30 2021-12-03 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
US10987354B2 (en) 2016-12-15 2021-04-27 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
JP7299837B2 (ja) 2016-12-23 2023-06-28 アクイナ ファーマシューティカルズ， インコーポレイテッド 化合物、組成物、および使用方法
WO2018127096A1 (en) 2017-01-05 2018-07-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CN110446711B (zh) * 2017-03-02 2022-02-15 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
CA3059449A1 (en) 2017-04-24 2018-11-01 Cocrystal Pharma, Inc. Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
CN108727369B (zh) * 2017-04-25 2023-06-09 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
CN120118069A (zh) * 2023-12-08 2025-06-10 武汉人福创新药物研发中心有限公司 Mrgprx2拮抗剂及用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080063809A (ko) * 2005-09-30 2008-07-07 버텍스 파마슈티칼스 인코포레이티드 야누스 키나아제의 억제제로서 유용한 데아자퓨린
SG10201405826RA (en) * 2009-06-17 2014-12-30 Vertex Pharma Inhibitors of influenza viruses replication
EA026201B1 (ru) * 2010-11-19 2017-03-31 Инсайт Холдингс Корпорейшн Циклобутилзамещенные производные пирролопиридина и пирролопиримидина как ингибиторы jak
RU2013132681A (ru) * 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
CA2822062A1 (en) * 2010-12-16 2012-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
UA118010C2 (uk) * 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу

Also Published As

Publication number Publication date
HUE053595T2 (hu) 2021-07-28
IL250955A0 (en) 2017-04-30
PH12017500393A1 (en) 2017-07-17
LT3191489T (lt) 2021-01-25
DK3191489T3 (da) 2021-03-29
EA201790571A1 (ru) 2017-08-31
CA2957475A1 (en) 2016-03-17
CL2017000533A1 (es) 2017-10-06
SI3191489T1 (sl) 2021-02-26
KR102531340B1 (ko) 2023-05-10
BR112017004524A2 (pt) 2017-12-05
US9932346B2 (en) 2018-04-03
CN106661036B (zh) 2022-03-15
ES2860688T3 (es) 2021-10-05
US20170253600A1 (en) 2017-09-07
WO2016037953A1 (en) 2016-03-17
ZA201701643B (en) 2018-12-19
AU2015314394A1 (en) 2017-03-02
SG11201701621YA (en) 2017-03-30
EP3191489A1 (en) 2017-07-19
ES2860688T8 (es) 2022-01-18
EP3191489B1 (en) 2021-01-06
JP2017527619A (ja) 2017-09-21
HRP20210038T1 (hr) 2021-03-05
CN106661036A (zh) 2017-05-10
JP6718451B2 (ja) 2020-07-08
KR20170054420A (ko) 2017-05-17

Similar Documents

Publication Publication Date Title
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
PH12017500207A1 (en) Indoles for use in influenza virus infection
MX381314B (es) Pirimidinas sustituidas con arilo para su uso en la infeccion por virus influenza
SI3347352T1 (sl) Terapevtske spojine uporabne za profilaktično ali terapevtsko zdravljenje okužbe z virusom HIV
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
PH12016501254A1 (en) Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
MX2017006302A (es) Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias.
EA030115B9 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
IL280769A (en) New sulfonimidylpurinone compounds and their history for the treatment and prevention of virus infection
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
EA202091849A1 (ru) Тиазолидные соединения для лечения вирусных инфекций
EA201791174A1 (ru) Антимикотическое соединение
MX2017004655A (es) Compuestos de hidroxil purinas y aplicaciones de estos.
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
EA201690594A1 (ru) Состав для лечения вич-инфекции на основе атазанавира и кобицистата
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
MX2016009250A (es) Nuevos imidazoles para el tratamiento y profilaxis de la infeccion por virus sincicial respiratorio.